Recruiting
Phase 3

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

Sponsor:

Novartis Pharmaceuticals

Code:

NCT05755386

Conditions

IC-MPGN

Eligibility Criteria

Sex: All

Age: 12 - 60

Healthy Volunteers: Not accepted

Interventions

Placebo

iptacopan

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information